# Cellectis (CLLS) — Analyst Forecast

CLLS · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/clls/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 16, 2026 | Barclays | Downgraded | Overweight → Underweight | $1.30 |
| Sep 15, 2026 | Wells Fargo | Maintained | Equal-Weight | $3.00 |
| Sep 15, 2026 | Baird | Maintained | Outperform | $8.00 |
| Sep 15, 2026 | Citizens | Downgraded | Market Outperform → Market Perform | — |
| May 28, 2026 | Barclays | Initiated Coverage | Overweight | $9.00 |
| Apr 14, 2026 | Citizens | Maintained | Market Outperform | $8.00 |
| Dec 23, 2025 | Clear Street | Initiated Coverage | Buy | $9.00 |
| Oct 17, 2025 | Barclays | Maintained | Overweight | $8.00 |
| May 13, 2025 | Barclays | Maintained | Overweight | $4.00 |
| Nov 5, 2024 | Barclays | Maintained | Overweight | $5.00 |
| Jun 12, 2024 | Oppenheimer | Maintained | Outperform | $10.00 |
| May 31, 2024 | JMP Securities | Maintained | Market Outperform | $6.00 |
| Nov 1, 2023 | JMP Securities | Maintained | Market Outperform | $6.00 |
| Aug 8, 2023 | Oppenheimer | Maintained | Outperform | $11.00 |
| Aug 7, 2023 | JMP Securities | Maintained | Market Outperform | $6.00 |

## Frequently Asked Questions

### What is the latest analyst rating on CLLS?

On Sep 16, 2026, Barclays downgraded Cellectis to Underweight with a price target of $1.30.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).